ELAN Elanco Animal Health Inc Insider Trading

Modi Rajeev A. bought 4,911 shares of ELAN at $20.35 on 2026-05-15; stock now down -28.6% from 52-week high.

Modi Rajeev A. purchased 4,911 shares at $20.35 on 2026-05-15, increasing holdings by 3.2% to 160,812 shares post-transaction. The transaction occurs as ELAN trades at $19.80, down -16.4% over 30 days and down -28.6% from its 52-week high of $27.72. While Modi's prior buy at this ticker (2025-12-11) produced positive 90-day returns and was well-timed, the current price action presents a contrasting backdrop. The company generated $1,371,000,000 in latest quarterly revenue with a market cap of $9,889,101,743.40, though it reported negative full-year net income despite posting $57,000,000 in quarterly net income. The timing of this purchase against the stock's recent downward trajectory and the company's broader profitability challenges merit investor attention.

CEO Simmons buys 4,971 shares of ELAN at $20.08; stock down -28.6% from 52-week high

CEO and President Jeffrey N Simmons purchased 4,971 shares at $20.08 on 2026-05-15, increasing his holdings to 171,971 shares. The purchase occurs against a backdrop of material price weakness: the stock trades at $19.80, down -28.6% from its 52-week high of $27.72 and down -16.4% over the prior 30 days. Fundamentals show the company generated $1,371,000,000 in quarterly revenue with annual revenue growth of 6.2%, though the company was unprofitable over its most recent full fiscal year. The timing of this insider purchase during a period of elevated price pressure warrants attention, particularly given the stock's cumulative decline across multiple timeframes.